Angiogenesis


During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
B5675 ObtustatinSummary: integrin α1β1 inhibitor -
B5699 P11Summary: antagonist of the integrin αvβ3-vitronectin interaction -
C6371 Calcium dobesilate -
B6664 GR 144053 trihydrochlorideSummary: platelet fibrinogen receptor glycoprotein IIb/IIIa (GpIIb/IIIa) antagonist -
B6764 Combretastatin A4Summary: tubulin polymerization inhibitor -
B7157 OGT 2115Target: HeparanasesSummary: Heparanase inhibitor -
B7741 BIO 51921 CitationSummary: α4β1 inhibitor -
A4507 KC7F25 CitationSummary: HIF-1α inhibitor -
A4509 PX 121 CitationTarget: TrxSummary: Trx-1 inhibitor -
A4506 DMOG5 CitationTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: Competitive HIF-PH inhibitor, cell-permeable
